auto_awesome
Tracking this entity every week?
Watch this entity, get an email digest the moment they win, lose, or are recompete-eligible. Free on every plan.
Providence Therapeutics Holdings Inc.
SaveTotal Grants
8
Total Amount
$96.4M
Top Departments by Funding Amount
| # | Department | Grants | Total Amount |
|---|---|---|---|
| 1 | Innovation, Science and Economic Development Canada | 1 | $49.9M |
| 2 | National Research Council Canada | 7 | $46.5M |
Top Programs by Funding Amount
| # | Program | Grants | Total Amount |
|---|---|---|---|
| 1 | SIF Stream2- Growth | 1 | $49.9M |
| 2 | Industrial Research Assistance Program – Contributions to Firms | 7 | $46.5M |
Recent Grants
Page 1 of 1 · 8 total grants
Department
Amount
Year
Purpose
Innovation, Science and Economic Development Canada
$49.9M
--
Enhancing Canadian Innovation in Biomanufacturing and R&D in mRNA Medicines
National Research Council Canada
$10.0M
--
Providence Therapeutics intends to continue the clinical development of a made-i...
National Research Council Canada
$8.7M
--
The Firm is Canada's leader in mRNA therapeutics and this project's main goal is...
National Research Council Canada
$8.6M
--
The Firm is Canada's leader in mRNA therapeutics and this project's main goal is...
National Research Council Canada
$6.4M
--
Providence Therapeutics, Canada’s leading mRNA vaccine manufacture, is manufactu...
National Research Council Canada
$6.4M
--
Providence Therapeutics, Canada’s leading mRNA vaccine manufacture, is manufactu...
National Research Council Canada
$4.7M
--
Providence Therapeutics, Canada’s leading mRNA vaccine manufacture, is manufactu...
National Research Council Canada
$1.8M
--
This proposal aims to develop a made-in-Canada solution to the threat posed by H...
Innovation, Science and Economic Development Canada
$49.9M--
Enhancing Canadian Innovation in Biomanufacturing and R&D in mRNA Medicines
National Research Council Canada
$10.0M--
Providence Therapeutics intends to continue the clinical development of a made-in-Canada mRNA vaccine against COVID-19. ...
National Research Council Canada
$8.7M--
The Firm is Canada's leader in mRNA therapeutics and this project's main goal is to continue the development of PTX-COVI...
National Research Council Canada
$8.6M--
The Firm is Canada's leader in mRNA therapeutics and this project's main goal is to continue the development of PTX-COVI...
National Research Council Canada
$6.4M--
Providence Therapeutics, Canada’s leading mRNA vaccine manufacture, is manufacturing an mRNA vaccine against COVID-19. T...
National Research Council Canada
$6.4M--
Providence Therapeutics, Canada’s leading mRNA vaccine manufacture, is manufacturing an mRNA vaccine against COVID-19. T...
National Research Council Canada
$4.7M--
Providence Therapeutics, Canada’s leading mRNA vaccine manufacture, is manufacturing an mRNA vaccine against COVID-19. T...
National Research Council Canada
$1.8M--
This proposal aims to develop a made-in-Canada solution to the threat posed by Highly Pathogenic Avian Influenza (HPAI) ...
Explore More Government Data
IT Spending by Department
Federal technology budgets and consulting spend trends
Departmental Budgets
Budget breakdowns for every federal department and agency
Federal Contracts
Search 1.3M+ government contracts from the Open Government Portal
Contract Awards
Track who wins government contracts and award patterns
Standing Offers
Browse TBIPS, ProServices, and other procurement vehicles
Buy Canadian Policy
Guide to the 2025-2026 domestic procurement policy
Indigenous Procurement
PSAB, mandatory set-asides, and the 5% target